Ömer ÖZBUDAK, İrem Hicran ÖZBUDAK, Hülya DİROL

A Rare Primary Lung Tumor: Pulmonary Epithelioid Hemangioendothelioma and a Literature Review

Epithelioid hemangioendothelioma is an extremely rare vascular tumor, with a prevalence of less thanone in one million each year. It is most commonly described in the veins of the extremities, but it mayalso arise from the vascular endothelial or pre-endothelial cells of the lung. Most of the patients areyoung women. The clinical behavior of pulmonary endotheloid hemangioma (PEH) ranges from welldifferentiatedhemangioma to high-grade angiosarcoma. Chest CT is characterized by the presence of anodule that is either single or multiple in one lung or both. For the diagnosis, a good histopathologicalevaluation of the biopsy is required. Depending on the rarity of the disease, there is no standardizationin treatment. Chemotherapy can be administered for widespread disease, with unclear benefits. Drugsthat block the vascular endothelial growth factor are expected to be effective with a small number ofpromising case reports. What we know about the disease and how to manage is all those derived fromapproximately 250 case reports. Thus, we aimed to present one more patient with bilateral pulmonaryepithelioid hemangioma with two years follow up results after some chemotherapy.

PDF

___

1. Lau K, Massad M, Pollak C, Rubin C, Yeh J, Wang J, et al. Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer. Chest 2011;140(5):1312–8.
2. Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer 1982;50(5):970–81.
3. World Health Organization (WHO); International Association for Research on Cancer: In World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Fletcher CDM, Unni KK, Mertens F, editors. Lyon, France: IARC Press; 2002. Available at: https://aaot. org.ar/_docs/pdfs/who-classification.pdf. Accessed Mar 12, 2020.
4. Scordi-Bello IA, Snyder A, Schwartz M, Fallon JT. Intravascular epithelioid hemangioendothelioma of the inferior vena cava: case report of an unusual and unpredictable vascular tumor. Cardiovasc Pathol 2009;18(4):243–6.
5. Okamura K, Ohshima T, Nakano R, Ouchi H, Takayama K, Nakanishi Y. A case of pulmonary epithelioid hemangioendothelioma surviving 10 years without treatment. Ann Thorac Cardiovasc Surg 2010;16(6):432–5.
6. Fujita K. Long term follow-up of a case of pulmonary epithelioid hemangioendothelioma. [Article in Japanese] Kyobu Geka 2009;62(3):223–6.
7. Chevreau C, Le Cesne A, Ray-Coquard I, Italiano A, Cioffi A, Isambert N, et al. Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/ GETO). Cancer 2013;119(14):2639–44.
8. Schattenberg T, Kam R, Klopp M, Herpel E, Schnabel PA, Mechtersheimer G, et al. Pulmonary epithelioid hemangioendothelioma: report of three cases. Surg Today 2008;38(9):844–9.
9. Weissferdt A, Moran CA. Primary vascular tumors of the lungs: a review. Ann Diagn Pathol 2010;14(4):296–308.
10. Weiss SW, Ishak KG, Dail DH, Sweet DE, Enzinger FM. Epithelioid hemangioendothelioma and related lesions. Semin Diagn Pathol 1986;3(4):259–87.
11. Dean PJ, Haggitt RC, O’Hara CJ. Malignant epithelioid hemangioendothelioma of the liver in young women. Relationship to oral contraceptive use. Am J Surg Pathol 1985;9(10):695–704.
12. Sicilian L, Warson F, Carrington CB, Hayes J, Gaensler EA. Intravascular bronchioloalveolar tumor (IV-BAT). Respiration 1983;44(5):387–94.
13. Amin RM, Hiroshima K, Kokubo T, Nishikawa M, Narita M, Kuroki M, et al. Risk factors and independent predictors of survival in patients with pulmonary epithelioid haemangioendothelioma. Review of the literature and a case report. Respirology 2006;11(6):818–25.
14. Ye B, Li W, Feng J, Shi JX, Chen Y, Han BH. Treatment of pulmonary epithelioid hemangioendothelioma with combination chemotherapy: Report of three cases and review of the literature. Oncol Lett 2013;5(5):1491–6.
15. Mizota A, Shitara K, Fukui T. Bevacizumab chemotherapy for pulmonary epithelioid hemangioendothelioma with severe dyspnea. J Thorac Oncol 2011;6(3):651–2.